Literature DB >> 11714443

High frequency of deletions at the hypoxanthine-guanine phosphoribosyltransferase locus in an ataxia-telangiectasia lymphoblastoid cell line irradiated with gamma-rays.

A Tachibana1, K Tatsumi, I Furuno-Fukushi, M S Sasaki.   

Abstract

The molecular nature of gamma-ray-induced mutations at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in an ataxia-telangiectasia (A-T) lymphoblastoid cell line was investigated. Twelve of 15 gamma-ray-induced HPRT-deficient mutants showed deletions. Eight of them had lost the entire HPRT gene, one showed a 1.9-kb deletion, and three had deletions of about 40-150 base pairs. Of the eight mutants that lost the entire gene, five had also lost both DXS79 and DXS86, flanking markers of the HPRT locus. The spectrum of mutations induced by gamma-irradiation in the A-T cells showed a high frequency of deletions in comparison with that in a control cell line, WIL2-NS. Sequence analysis of breakpoint junctions in four mutants revealed that three of them had junctions between short identical sequences at each breakpoint, leaving one copy at the junction. These results suggest that non-homologous end-joining is the major mechanism for deletion formation in A-T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714443      PMCID: PMC5926665          DOI: 10.1111/j.1349-7006.2001.tb02139.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  45 in total

1.  Specific chromosome aberrations in ataxia telangiectasia.

Authors:  J M Oxford; D G Harnden; J M Parrington; J D Delhanty
Journal:  J Med Genet       Date:  1975-09       Impact factor: 6.318

Review 2.  DNA damage and cell cycle checkpoints.

Authors:  W K Kaufmann; R S Paules
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

3.  Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.

Authors:  R Varon; C Vissinga; M Platzer; K M Cerosaletti; K H Chrzanowska; K Saar; G Beckmann; E Seemanová; P R Cooper; N J Nowak; M Stumm; C M Weemaes; R A Gatti; R K Wilson; M Digweed; A Rosenthal; K Sperling; P Concannon; A Reis
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

4.  Analysis of large deletions in the HPRT gene of primary human fibroblasts using the polymerase chain reaction.

Authors:  T Morris; W Masson; B Singleton; J Thacker
Journal:  Somat Cell Mol Genet       Date:  1993-01

5.  High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia.

Authors:  A Aurias; B Dutrillaux; D Buriot; J Lejeune
Journal:  Mutat Res       Date:  1980-02       Impact factor: 2.433

6.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

Review 7.  Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.

Authors:  R A Gatti; E Boder; H V Vinters; R S Sparkes; A Norman; K Lange
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

8.  Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families.

Authors:  R A Gibbs; P N Nguyen; A Edwards; A B Civitello; C T Caskey
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

Review 9.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

10.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.